Invitrogen Believed to Be Exploring Acquisition of Incyte Genomics | GenomeWeb

NEW YORK, Nov. 6 – Invitrogen is exploring the possibility of acquiring Incyte Genomics, a source inside Invitrogen told GenomeWeb.    

The source, a senior-level employee who asked not to be named, said that the company is interested in acquiring the genomics data provider but is waiting to act until the price is right.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.